Skip to content

MemFlex to Prevent Depressive Relapse

A Randomised Controlled Trial of the Efficacy of Autobiographical Memory Flexibility (MemFlex) Training in Preventing Relapse of Recurrent Depression

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02614326
Enrollment
70
Registered
2015-11-25
Start date
2016-01-31
Completion date
2020-12-31
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Keywords

Depression, Cognitive risk factors, Autobiographical memory, Cognitive bias, Relapse prevention

Brief summary

A wealth of research has demonstrated that they way in which the investigators recall our personal, autobiographical memories is influential in the course of depression. Biases in the recall of autobiographical memory occur in the midst of a depressive episode, and are shown to prolong symptoms, however these biases also remain when depression remits, and may predispose the individual towards relapse. A novel cognitive intervention, MemFlex, aims to train individuals to be flexible in their retrieval of autobiographical memories, and thereby reduce depressive relapse. Changes in memory bias may also have an effect on intermediate processes that increase risk of depression, such as rumination, impaired problem solving, and cognitive avoidance. This feasibility trial compares the effects of MemFlex and Psychoeducation in their ability to reduce memory bias and intermediate cognitive risk factors, and thereby depressive relapse, in individuals remitted from Major Depressive Disorder. Clinical outcome and process measures will be assessed immediately following completion of the intervention, at 6 months post-intervention, and at 12 months post-intervention. If encouraging, the results of this pilot trial may provide a foundation for a later phase trial.

Interventions

BEHAVIORALAutobiographical Memory Flexibility (MemFlex) training

As in experimental arm description

BEHAVIORALPsychoeducation

As in experimental arm description

Sponsors

Medical Research Council Cognition and Brain Sciences Unit
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Meets criteria for Major Depressive Disorder but is currently in remission, indexed on the Structured Clinical Interview for the DSM (SCID; First et al., 1996) * 18 years of age or older

Exclusion criteria

* Meets criteria for a current Major Depressive Episode, indexed on the SCID * Meets criteria for another mood disorder (e.g., Bipolar disorder), indexed on the SCID * Current alcohol or substance dependence, or currently experiencing psychotic symptoms, indexed on the SCID * Experience of intellectual disability, traumatic brain injury, or other neurological condition which may impact memory recall, assessed via self-report

Design outcomes

Primary

MeasureTime frameDescription
Time to depressive relapse12 months post-interventionLength of time from post-intervention assessment to occurrence of any major depressive episode within the 12 month follow-up period
Number of depression free days at 12 month follow-up12 months post-interventionNumber of depression free days as indexed by the Longitudinal Interval Follow-up Evaluation (Keller et al., 1987)

Secondary

MeasureTime frameDescription
Depressive status at 12 month follow-up12 months post-interventionPresence of a Major Depressive Episode as indexed by the Longitudinal Interval Follow-up Evaluation (Keller et al., 1987)
Depression symptoms at 12 month follow-up12 months post-interventionScore on the Beck Depression Inventory
Autobiographical memory retrievalMeasured within one week of completing the interventionScores for specific and alternating blocks of the alternating instructions autobiographical memory task (Dritschel et al., 2013)

Other

MeasureTime frameDescription
RuminationMeasured within one week of completing the intervention, six months post-intervention and 12 months post-interventionTotal and sub-scale scores on the Rumination Response Scale (Treynor, Gonzalez, Nolen-Hoeksema, 2003)
Cognitive avoidanceMeasured within one week of completing the intervention, six months post-intervention and 12 months post-interventionTotal score on the Cognitive Avoidance Questionnaire (Sexton & Dugas, 2008)
Problem solvingMeasured within one week of completing the intervention, and six months post-interventionThe total number of means and total effectiveness scores on the abbreviated version of the Means-Ends Problem Solving task (Marx, Williams, & Claridge, 1992)
Anxiety symptomsMeasured within one week of completing the intervention, six months post-intervention and 12 months post-interventionTotal score on the Beck Anxiety Inventory (Beck & Steer, 1993)
HopelessnessMeasured within one week of completing the intervention, six months post-intervention and 12 months post-interventionTotal score on the Beck Hopelessness Scale (Beck, Weissman, Lester, & Trexler, 1974)

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026